Frontiers in Plant Science,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 9, 2023
CRISPR-Cas9,
the
“genetic
scissors”,
is
being
presaged
as
a
revolutionary
technology,
having
tremendous
potential
to
create
designer
crops
by
introducing
precise
and
targeted
modifications
in
genome
achieve
global
food
security
face
of
climate
change
increasing
population.
Traditional
genetic
engineering
relies
on
random
unpredictable
insertion
isolated
genes
or
foreign
DNA
elements
into
plant
genome.
However,
CRISPR-Cas
based
gene
editing
does
not
necessarily
involve
inserting
element
from
different
species
but
new
traits
precisely
altering
existing
genes.
CRISPR
edited
are
touching
markets,
however,
world
community
divided
over
whether
these
should
be
considered
genetically
modified
(GM)
non-GM.
Classification
crops,
especially
transgene
free
traditional
GM
will
significantly
affect
their
future
public
acceptance
some
regions.
Therefore,
depending
upon
regulation
non-GMs,
perception.
Here
we
briefly
discuss
how
crops.
In
addition,
reagents
delivery
tools
produce
transgene-free
Moreover,
also
summarize
regulatory
classification
countries
regulating
We
that
controversy
CRISPR-edited
plants
non-GM
continue
until
universal,
transparent,
scalable
framework
for
introduced
worldwide,
with
increased
awareness
involving
all
stakeholders.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 16, 2023
Abstract
Clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/CRISPR-associated
protein
9
(Cas9)
gene-editing
technology
is
the
ideal
tool
of
future
for
treating
diseases
by
permanently
correcting
deleterious
base
mutations
or
disrupting
disease-causing
genes
with
great
precision
and
efficiency.
A
variety
efficient
Cas9
variants
derivatives
have
been
developed
to
cope
complex
genomic
changes
that
occur
during
diseases.
However,
strategies
effectively
deliver
CRISPR
system
diseased
cells
in
vivo
are
currently
lacking,
nonviral
vectors
target
recognition
functions
may
be
focus
research.
Pathological
physiological
resulting
from
disease
onset
expected
serve
as
identifying
factors
targeted
delivery
targets
gene
editing.
Diseases
both
varied
complex,
choice
appropriate
methods
different
important.
Meanwhile,
there
still
many
potential
challenges
identified
when
targeting
CRISPR/Cas9
treatment.
This
paper
reviews
current
developments
three
aspects,
namely,
type,
vector,
characteristics.
Additionally,
this
summarizes
successful
examples
clinical
trials
finally
describes
possible
problems
associated
applications.
Biologics,
Journal Year:
2021,
Volume and Issue:
Volume 15, P. 353 - 361
Published: Aug. 1, 2021
Abstract:
Clustered
regularly
interspaced
short
palindromic
repeat
(CRISPR)
and
their
associated
protein
(Cas-9)
is
the
most
effective,
efficient,
accurate
method
of
genome
editing
tool
in
all
living
cells
utilized
many
applied
disciplines.
Guide
RNA
(gRNA)
CRISPR-associated
proteins
are
two
essential
components
CRISPR/Cas-9
system.
The
mechanism
contains
three
steps,
recognition,
cleavage,
repair.
designed
sgRNA
recognizes
target
sequence
gene
interest
through
a
complementary
base
pair.
While
Cas-9
nuclease
makes
double-stranded
breaks
at
site
3
pair
upstream
to
protospacer
adjacent
motif,
then
break
repaired
by
either
non-homologous
end
joining
or
homology-directed
repair
cellular
mechanisms.
genome-editing
has
wide
number
applications
areas
including
medicine,
agriculture,
biotechnology.
In
it
could
help
design
new
grains
improve
nutritional
value.
being
investigated
for
cancers,
HIV,
therapy
such
as
sickle
cell
disease,
cystic
fibrosis,
Duchenne
muscular
dystrophy.
technology
also
regulation
specific
genes
advanced
modification
protein.
However,
immunogenicity,
effective
delivery
systems,
off-target
effect,
ethical
issues
have
been
major
barriers
extend
clinical
applications.
Although
becomes
era
molecular
biology
countless
roles
ranging
from
basic
researches
applications,
there
still
challenges
rub
practical
various
improvements
needed
overcome
obstacles.
Keywords:
CRISPR,
Cas-9,
sgRNA,
gene-editing,
mechanism,
Chemical Society Reviews,
Journal Year:
2021,
Volume and Issue:
50(9), P. 5435 - 5467
Published: Jan. 1, 2021
Biomedical
applications
of
fluoropolymers
in
gene
delivery,
protein
drug
delivery,19F
MRI,
PDT,
anti-fouling,
anti-bacterial,
cell
culture,
and
tissue
engineering.
Accounts of Chemical Research,
Journal Year:
2022,
Volume and Issue:
55(5), P. 722 - 733
Published: Feb. 17, 2022
The
cytosolic
delivery
of
biomolecules
such
as
genes,
proteins,
and
peptides
is
great
importance
for
biotherapy
but
usually
limited
by
multiple
barriers
during
the
process.
Cell
membrane
with
high
hydrophobic
character
one
representative
biological
delivery.
introduction
ligands
aliphatic
lipids
onto
materials
or
could
improve
their
permeability.
However,
these
are
lipophilic
tend
to
interact
phospholipids
in
well
serum
which
may
hinder
efficient
intracellular
To
solve
this
issue,
our
research
group
proposed
use
fluorous
both
hydrophobicity
lipophobicity
ideal
alternatives
promote
delivery.In
first
attempt,
were
conjugated
cationic
polymers
increase
gene
efficacy.
fluorination
dramatically
increased
performance
at
low
polymer
doses.
In
addition,
strategy
greatly
improved
tolerance
polymers,
critical
vivo.
Besides
tolerance,
mechanism
studies
revealed
that
increases
steps
cellular
uptake
endosomal
escape.
Fluorination
also
allowed
assembly
low-molecular-weight
achieved
highly
minimal
material
toxicity.
method
showed
robust
efficiency
including
linear
branched
dendrimers,
bola
amphiphilies,
dendronized
polymers.Besides
delivery,
fluorinated
used
protein
via
a
coassembly
strategy.
For
purpose,
two
lead
fluoropolymers
screened
from
library
amphiphilic
materials.
superior
nonfluorinated
analogues
lipids.
beneficial
encapsulation,
reduced
denaturation,
facilitated
endocytosis,
decreased
toxicity
compared
exhibited
potent
efficacy
therapeutic
peptide
achieve
cancer
therapy
able
fabricate
personalized
nanovaccine
immunotherapy.
Finally,
directly
disulfide
bond
Fluorous
drive
cargo
into
uniform
nanoparticles
much
proteolytic
stability
various
types
cells.
traditional
techniques
cell-penetrating
vitro
Overall,
provide
promising
strategies
biomolecules.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Jan. 9, 2024
Abstract
The
CRISPR
system
is
a
revolutionary
genome
editing
tool
that
has
the
potential
to
revolutionize
field
of
cancer
research
and
therapy.
ability
precisely
target
edit
specific
genetic
mutations
drive
growth
spread
tumors
opened
up
new
possibilities
for
development
more
effective
personalized
treatments.
In
this
review,
we
will
discuss
different
CRISPR-based
strategies
have
been
proposed
therapy,
including
inactivating
genes
tumor
growth,
enhancing
immune
response
cells,
repairing
cause
cancer,
delivering
cancer-killing
molecules
directly
cells.
We
also
summarize
current
state
preclinical
studies
clinical
trials
highlighting
most
promising
results
challenges
still
need
be
overcome.
Safety
delivery
are
important
therapy
become
viable
option.
limitations
overcome,
such
as
off-target
effects,
safety,
site.
Finally,
provide
an
overview
opportunities
in
future
directions
development.
change
landscape
research,
review
aims
overcome
realize
potential.
Frontiers in Plant Science,
Journal Year:
2023,
Volume and Issue:
14
Published: March 13, 2023
Genome
editing
techniques
are
being
used
to
modify
plant
breeding,
which
might
increase
food
production
sustainably
by
2050.
A
product
made
feasible
genome
is
becoming
better
known,
because
of
looser
regulation
and
widespread
acceptance.
The
world’s
population
supply
would
never
have
increased
proportionally
under
current
farming
practices.
development
plants
has
been
greatly
impacted
global
warming
climate
change.
Therefore,
minimizing
these
effects
crucial
for
agricultural
that
sustainable.
Crops
more
resilient
abiotic
stress
sophisticated
practices
a
understanding
the
response
mechanism.
Both
conventional
molecular
breeding
create
viable
crop
types
both
processes
time-consuming.
Recently,
breeders
shown
an
interest
in
approaches
genetic
manipulation
use
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR/Cas9).
To
ensure
security
future,
kinds
with
desired
traits
must
be
developed.
completely
new
era
begun
revolution
based
on
CRISPR/CRISPR-associated
nuclease
(Cas9)
systems.
All
may
effectively
target
particular
gene
or
group
loci
using
Cas9
single-guide
RNA
(sgRNA).
CRISPR/Cas9
can
thereby
save
time
labor
compared
methods.
An
easy,
quick,
efficient
method
directly
altering
sequences
cells
CRISPR
CRISPR-Cas9
system,
was
developed
from
components
earliest
known
bacterial
immune
allows
targeted
breakage
variety
cells/RNA
guide
endonuclease
cleavage
specificity
system.
Editing
directed
practically
any
genomic
site
(gRNA)
sequence
delivering
it
cell
along
endonuclease.
We
summarize
recent
research
findings,
investigate
potential
applications
make
predictions
about
likely
future
breakthroughs
through
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
92, P. 105338 - 105338
Published: Jan. 6, 2024
The
rapid
advancement
of
CRISPR-Cas9
technology
has
instigated
a
profound
transformation
in
genome
editing
with
significant
implications
for
fields
like
health,
agriculture,
and
biotechnology.
This
abstract
provides
an
overview
the
historical
significance
fundamental
components
CRISPR-Cas9,
notably
Cas9
protein
guide
RNA,
underscoring
its
pivotal
role
genetic
manipulation.
It
emphasizes
CRISPR-Cas9's
preeminence
domain
precise
editing,
driving
breakthroughs
personalized
medicine,
gene
therapy,
agriculture.
Of
paramount
importance
is
integration
nanomaterials,
encompassing
lipid-based
polymeric
nanoparticles,
alongside
viral
vectors,
serving
as
potent
vehicles
augmenting
delivery
efficiency
precision.
We
explore
strategies
aimed
at
enhancing
through
while
also
addressing
ethical
regulatory
considerations.
In
expert
opinion
section,
we
offer
nuanced
perspective
on
present
state
field,
highlighting
potential
transformative
progress
research
therapy.
stands
brink
unlocking
new
possibilities
providing
innovative
solutions
to
address
pressing
global
challenges.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 26, 2024
The
delivery
of
CRISPR
ribonucleoproteins
(RNPs)
for
genome
editing
in
vitro
and
vivo
has
important
advantages
over
other
methods,
including
reduced
off-target
immunogenic
effects.
However,
effective
RNPs
remains
challenging
certain
cell
types
due
to
low
efficiency
toxicity.
To
address
these
issues,
we
engineer
self-deliverable
that
can
promote
efficient
cellular
uptake
carry
out
robust
without
the
need
helper
materials
or
biomolecules.
Screening
cell-penetrating
peptides
(CPPs)
fused
CRISPR-Cas9
protein
identifies
potent
constructs
capable
neural
progenitor
cells.
Further
engineering
fusion
proteins
establishes
a
C-terminal
Cas9
with
three
copies
A22p,
peptide
derived
from
human
semaphorin-3a,
exhibits
substantially
improved
efficacy
compared
constructs.
We
find
generate
edits
clinically
relevant
genes
when
injected
directly
into
mouse
striatum.
Overall,
provide
facile
platform
vivo.
Advanced Drug Delivery Reviews,
Journal Year:
2021,
Volume and Issue:
178, P. 113908 - 113908
Published: Aug. 11, 2021
Drug
delivery
systems
or
vectors
are
usually
needed
to
improve
the
bioavailability
and
effectiveness
of
a
drug
through
improving
its
pharmacokinetics/pharmacodynamics
at
an
organ,
tissue
cellular
level.
However,
emerging
technologies
with
sensitive
readouts
as
well
greater
understanding
physiological/biological
have
revealed
that
polymeric
not
biologically
inert
but
can
innate
intrinsic
biological
actions.
In
this
article,
we
review
multiple
biological/toxicological
properties
naked
polyamidoamine
(PAMAM)
dendrimer
in
absence
any
cargo
discuss
their
correlation
defined
physicochemical
PAMAMs
terms
molecular
size
(generation),
architecture,
surface
charge
chemistry.
Further,
assess
whether
reported
actions
such
antimicrobial
activity
ability
sequester
glucose
modulate
key
protein
interactions
cell
signaling
pathways,
be
exploited
clinically
treatment
diabetes
complications.